186 related articles for article (PubMed ID: 25476893)
1. PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway.
Pan Y; Rhea P; Tan L; Cartwright C; Lee HJ; Ravoori MK; Addington C; Gagea M; Kundra V; Kim SJ; Newman RA; Yang P
Invest New Drugs; 2015 Apr; 33(2):271-9. PubMed ID: 25476893
[TBL] [Abstract][Full Text] [Related]
2. Does the Nerium oleander extract PBI-05204 have potential for pancreatic cancer therapy?
Calderón-Montaño JM; Burgos-Morón E; Guillén-Mancina E; López-Lázaro M
Invest New Drugs; 2015 Jun; 33(3):787. PubMed ID: 25698441
[No Abstract] [Full Text] [Related]
3. Response to: Does the Nerium oleander extract PBI-05204 have potential for pancreatic cancer?
Newman RA; Yang P
Invest New Drugs; 2015 Jun; 33(3):788-9. PubMed ID: 25597755
[No Abstract] [Full Text] [Related]
4. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway.
Zhou HY; Yao XM; Chen XD; Tang JM; Qiao ZG; Wu XY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10283-10289. PubMed ID: 31841183
[TBL] [Abstract][Full Text] [Related]
5. The Botanical Drug PBI-05204, a Supercritical CO
Colapietro A; Yang P; Rossetti A; Mancini A; Vitale F; Martellucci S; Conway TL; Chakraborty S; Marampon F; Mattei V; Gravina GL; Biordi AL; Wei D; Newman RA; Festuccia C
Front Pharmacol; 2020; 11():552428. PubMed ID: 33013390
[TBL] [Abstract][Full Text] [Related]
6. First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.
Hong DS; Henary H; Falchook GS; Naing A; Fu S; Moulder S; Wheler JJ; Tsimberidou A; Durand JB; Khan R; Yang P; Johansen M; Newman RA; Kurzrock R
Invest New Drugs; 2014 Dec; 32(6):1204-12. PubMed ID: 24919855
[TBL] [Abstract][Full Text] [Related]
7. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.
Mu GG; Zhang LL; Li HY; Liao Y; Yu HG
Dig Dis Sci; 2015 Apr; 60(4):1067-80. PubMed ID: 25344906
[TBL] [Abstract][Full Text] [Related]
8. Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside.
Newman RA; Kondo Y; Yokoyama T; Dixon S; Cartwright C; Chan D; Johansen M; Yang P
Integr Cancer Ther; 2007 Dec; 6(4):354-64. PubMed ID: 18048883
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo neuroprotective activity of the cardiac glycoside oleandrin from Nerium oleander in brain slice-based stroke models.
Dunn DE; He DN; Yang P; Johansen M; Newman RA; Lo DC
J Neurochem; 2011 Nov; 119(4):805-14. PubMed ID: 21950737
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A.
Xu D; Zhou Y; Xie X; He L; Ding J; Pang S; Shen B; Zhou C
Int J Oncol; 2020 Nov; 57(5):1223-1233. PubMed ID: 32901837
[TBL] [Abstract][Full Text] [Related]
11. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.
Subramaniam D; Periyasamy G; Ponnurangam S; Chakrabarti D; Sugumar A; Padigaru M; Weir SJ; Balakrishnan A; Sharma S; Anant S
Mol Cancer Ther; 2012 Jul; 11(7):1598-608. PubMed ID: 22532602
[TBL] [Abstract][Full Text] [Related]
12. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
[TBL] [Abstract][Full Text] [Related]
13. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zhu J; Lv J; Chen J; Zhang X; Ji Y
Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
[No Abstract] [Full Text] [Related]
14. Efficacy of oleandrin and PBI-05204 against bovine viruses of importance to commercial cattle health.
Newman RA; Chase CCL; Matos JR; Abdelsalam K; Buterbaugh R; Van Holland S; Abdelaal H; Woolum A; Jagannadha Sastry K
Antivir Chem Chemother; 2022; 30():20402066221103960. PubMed ID: 35611441
[TBL] [Abstract][Full Text] [Related]
15. The Botanical Drug PBI-05204, a Supercritical CO
Colapietro A; Yang P; Rossetti A; Mancini A; Vitale F; Chakraborty S; Martellucci S; Marampon F; Mattei V; Gravina GL; Iorio R; Newman RA; Festuccia C
Front Pharmacol; 2022; 13():852941. PubMed ID: 35401175
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.
Plante KS; Dwivedi V; Plante JA; Fernandez D; Mirchandani D; Bopp N; Aguilar PV; Park JG; Tamayo PP; Delgado J; Shivanna V; Torrelles JB; Martinez-Sobrido L; Matos R; Weaver SC; Sastry KJ; Newman RA
Biomed Pharmacother; 2021 Jun; 138():111457. PubMed ID: 33721754
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways.
Li J; Liang X; Yang X
Oncol Rep; 2012 Aug; 28(2):501-10. PubMed ID: 22641480
[TBL] [Abstract][Full Text] [Related]
18. The botanical drug PBI-05204, a supercritical CO
Vaccaro S; Rossetti A; Porrazzo A; Camero S; Cassandri M; Pomella S; Tomaciello M; Macioce G; Pedini F; Barillari G; Marchese C; Rota R; Cenci G; Tombolini M; Newman RA; Yang P; Codenotti S; Fanzani A; Megiorni F; Festuccia C; Minniti G; Gravina GL; Vulcano F; Milazzo L; Marampon F
Front Pharmacol; 2022; 13():1071176. PubMed ID: 36532747
[TBL] [Abstract][Full Text] [Related]
19. In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer.
Ito D; Fujimoto K; Mori T; Kami K; Koizumi M; Toyoda E; Kawaguchi Y; Doi R
Int J Cancer; 2006 May; 118(9):2337-43. PubMed ID: 16331623
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G
BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
